Different expression of CD146 in human normal and osteosarcoma cell lines
暂无分享,去创建一个
[1] S. Cai,et al. Up-regulation of METCAM/MUC18 promotes motility, invasion, and tumorigenesis of human breast cancer cells , 2011, BMC Cancer.
[2] C. Napoli,et al. CXCR4/YY1 inhibition impairs VEGF network and angiogenesis during malignancy , 2010, Proceedings of the National Academy of Sciences.
[3] C. Napoli,et al. Mediator subunits: gene expression pattern, a novel transcript identification and nuclear localization in human endothelial progenitor cells. , 2010, Biochimica et biophysica acta.
[4] Giancarlo Castellano,et al. The involvement of the transcription factor Yin Yang 1 in cancer development and progression , 2009, Cell cycle.
[5] P. Perrin,et al. CD146 and its Soluble Form Regulate Monocyte Transendothelial Migration , 2009, Arteriosclerosis, thrombosis, and vascular biology.
[6] A. Fernando,et al. Towards understanding the mode of action of the multifaceted cell adhesion receptor CD146. , 2009, Biochimica et biophysica acta.
[7] C. Napoli,et al. Deletion of Yin Yang 1 protein in osteosarcoma cells on cell invasion and CXCR4/angiogenesis and metastasis. , 2008, Cancer research.
[8] B. Alman,et al. Opportunities for improving the therapeutic ratio for patients with sarcoma. , 2007, The Lancet. Oncology.
[9] C. Napoli,et al. Cooperation between Myc and YY1 provides novel silencing transcriptional targets of α3β1-integrin in tumour cells , 2007, Oncogene.
[10] C. Napoli,et al. Expression of transcription factor Yin Yang 1 in human osteosarcomas. , 2006, European journal of cancer.
[11] B. Bonavida,et al. Transcription factor YY1: structure, function, and therapeutic implications in cancer biology , 2006, Oncogene.
[12] A. Heimberger,et al. A fully human antimelanoma cellular adhesion molecule/MUC18 antibody inhibits spontaneous pulmonary metastasis of osteosarcoma cells in vivo. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[13] D. Elder,et al. Isolation and functional characterization of the A32 melanoma-associated antigen. , 1994, Cancer research.